IGF-1 CA repeat variant and breast cancer risk in postmenopausal women

European Journal of Cancer

Volumn 43, Issue 11, 2007, Pages 1718-1722

  Gonzalez Zuloeta Ladd A M ^a   Liu, F ^a   Houben, M P W A ^a   Arias Vasquez A ^a   Siemes, C ^a   Janssens, A C J W ^a   Coebergh, J W W ^a   Hofman, A ^a   Janssen, J A M J L ^a   Stricker, B H Ch ^a   van Duijn, C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Insulin like growth factor 1; Polymorphism

Indexed keywords

ADENINE; CYTOSINE; SOMATOMEDIN BINDING PROTEIN;

ADULT; ARTICLE; BODY MASS; BREAST CANCER; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MENOPAUSE; NUCLEOTIDE REPEAT; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; WAIST HIP RATIO;

AGED; BREAST NEOPLASMS; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS;

EID: 34447289181     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.04.026     Document Type: Article

References (27)

1. Ibrahim Y.H., and Yee D. Insulin-like growth factor-I and cancer risk. Growth Horm IGF Res 14 (2004) 261-269
2. Marshman E., and Streuli C.H. Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function. Breast Cancer Res 4 (2002) 231-239
3. Ma J., Pollak M.N., Giovannucci E., et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91 (1999) 620-625
4. Hankinson S.E., Willett W.C., Colditz G.A., et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351 (1998) 1393-1396
5. Renehan A.G., Zwahlen M., Minder C., O'Dwyer S.T., Shalet S.M., and Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363 (2004) 1346-1353
6. Smith P.J., Wise L.S., Berkowitz R., Wan C., and Rubin C.S. Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263 (1988) 9402-9408
7. Richert M.M., and Wood T.L. The insulin-like growth factors (IGF) and IGF type I receptor during postnatal growth of the murine mammary gland: sites of messenger ribonucleic acid expression and potential functions. Endocrinology 140 (1999) 454-461
8. Jernstrom H., Deal C., Wilkin F., et al. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10 (2001) 377-384
9. Rosen C.J., Kurland E.S., Vereault D., et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 83 (1998) 2286-2290
10. Rietveld I., Janssen J.A., van Rossum E.F., et al. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol (Oxf) 61 (2004) 195-203
11. Missmer S.A., Haiman C.A., Hunter D.J., et al. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100 (2002) 332-336
12. Yu H., Li B.D., Smith M., Shi R., Berkel H.J., and Kato I. Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res Treat 70 (2001) 117-122
13. Wen W., Gao Y.T., Shu X.O., et al. Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 113 (2005) 307-311
14. DeLellis K., Ingles S., Kolonel L., et al. IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88 (2003) 277-282
15. Wagner K., Hemminki K., Israelsson E., et al. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92 (2005) 133-140
16. Cleveland R.J., Gammon M.D., Edmiston S.N., et al. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27 (2006) 758-765
17. Bageman E., Ingvar C., Rose C., and Jernstrom H. Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women. Br J Cancer 96 (2007) 712-717
18. Hofman A., Grobbee D.E., de Jong P.T., and van den Ouweland F.A. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 7 (1991) 403-422
19. Vaessen N., Heutink P., Janssen J.A., et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50 (2001) 637-642
20. Raymond M. R.F. Genepop (version 1.2): population genetics software for exact tests and ecumenism. J Heredity 86 (1986) 248-249
21. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
22. Macaskill P., Walter S.D., and Irwig L. A comparison of methods to detect publication bias in meta-analysis. Stat Med 20 (2001) 641-654
23. Figer A., Karasik Y.P., Baruch R.G., et al. Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr Med Assoc J 4 (2002) 759-762
24. Fletcher O., Gibson L., Johnson N., et al. Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14 (2005) 2-19
25. Augustin L.S., Dal Maso L., Franceschi S., et al. Association between components of the insulin-like growth factor system and endometrial cancer risk. Oncology 67 (2004) 54-59
26. Yu H., Shu X.O., Li B.D., et al. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk. Cancer Epidemiol Biomarkers Prev 12 (2003) 1067-1073
27. Pharoah P.D., Antoniou A., Bobrow M., Zimmern R.L., Easton D.F., and Ponder B.A. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31 (2002) 33-36